WebNov 17, 2024 · Cerebrospinal fluid (CSF) is a colorless fluid, produced in the ventricles of the brain, which acts as a buffer around the brain and spinal cord, to keep them safe from injury. Intrathecal (IT) chemotherapy is used to treat cancers that have entered into the CSF. When a cancer has gotten into the CSF, it may be called CNS (central nervous ... WebMar 20, 2014 · Cisplatin and Irinotecan (Camptosar) Paclitaxel (Taxol) and either 5-FU or capecitabine ; Other common drugs and drug combinations that can be used to treat …
Docetaxel - Drug Information - Chemocare
WebMar 28, 2024 · We compared the efficacy of an anticancer drug (cisplatin) with or without pretreatments of two anti-fibrotic drugs, nintedanib and pirfenidone, on the growth and invasion of cancer cells co-cultured with fibroblasts. ... Altorki, G. J. Markowitz, D. Gao, J. L. Port, A. Saxena, B. Stiles, T. McGraw, and V. Mittal, Nat. Rev ... WebMar 13, 2024 · Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer April 2, 2024 updated by: Hong Zong, The First Affiliated Hospital of Zhengzhou University. csmg medical group
A 3D culture system for evaluating the combined effects of cisplatin …
WebMar 23, 2024 · Carboplatin 5-fluorouracil (5-FU) Paclitaxel (Taxol) Docetaxel (Taxotere) Hydroxyurea Other drugs that are used less often include: Methotrexate Capecitabine A chemo drug may be used alone or combined with other drugs. Combining drugs can often shrink tumors better, but tend to cause more side effects. WebSep 27, 2024 · Indications for IP chemotherapy — Based on available clinical data, IP chemotherapy may be most useful in women with optimally debulked (to ≤1.0 cm) stage III epithelial ovarian cancer (EOC). Some patients with earlier-stage disease may also be candidates (see "Adjuvant therapy of early-stage (stage I and II) epithelial ovarian, … WebThis study aims to investigate the role of partial epithelial to mesenchymal transition (pEMT)-related proteins in modulating Cisplatin resistance in head and neck squamous cell carcinoma (HNSCC). SCC-25 cells were pre-treated with TGF-beta1 followed by transient Krüppel-like Factor 4 (KLF4)-overexpression and Cisplatin treatment. Cell growth, … csmg medical